|Study name||HCC IO|
|Study authors||Joe Yeong's Lab|
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma (HCC). The study found that total CD38+ cell proportion and CD38+CD68+ macrophage density predicts responsiveness to immune checkpoint blockade more accurately than PD-L1 scoring or CD8+ T cell density. Image shows mIHC/IF of HCC tumor microenvironment stained with DNA, PD-L1, CD38 and CD68.
|Specimen type||Human liver tissue|
Joey Jia Ying Lee
(ImmunoAtlas, Bioinformatics Institute, A*STAR)
|Last updated||9 Jul, 2021 (Fri),
This image is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Please acknowledge the creators if you re-use the image.